Skip to main content
Log in

Carcinostatic activity of a thiazolidinonylidene-hydrazonothiazolidinone derivative against DMBA-induced mammary carcinomata in female Sprague-Dawley rats

  • Specialia
  • Published:
Experientia Aims and scope Submit manuscript

Zusammenfassung

5-Methyl-3-(2-methylallyl)-2-[(3-methyl-4-oxo-2-thiazolidinyliden)-hydrazono]-4-thiazolidinon erwies sich bei guter therapeutischer Breite als stark karzinostatisch wirksam bei DMBA-induzierten Mamma-Karzinomen weiblicher Sprague-Dawley Ratten. Eine geringere chemotherapeutische Wirkung fand sich auch bei Walker CaSa 256, DMBA-induzierten Hautkarzinomen und Ehrlich Ascites Karzinom.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ch. Huggins, L. C. Grand andF. P. Brillantes, Nature, Lond.189, 204 (1961).

    Article  CAS  Google Scholar 

  2. No placebo-treated control group was included in these experiments, since the vehicle used for the suspension of GP 48 989 had previously been shown to be indifferent.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt-Ruppin, K.H., Meisels, A., Schott, E. et al. Carcinostatic activity of a thiazolidinonylidene-hydrazonothiazolidinone derivative against DMBA-induced mammary carcinomata in female Sprague-Dawley rats. Experientia 29, 823–825 (1973). https://doi.org/10.1007/BF01946310

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01946310

Keywords

Navigation